ProKidney Financial Statements From 2010 to 2026

Stocks . USA . 
Stock . ProKidney Corp
PROK Stock  USD 2.10  0.01  0.48%   
Analyzing historical trends in various income statement and balance sheet accounts from ProKidney Corp's financial statements helps investors evaluate the company's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting ProKidney Corp's valuation are summarized below:
Gross Profit
744 K
Market Capitalization
628.7 M
Enterprise Value Revenue
161.2372
Revenue
744 K
Earnings Share
(0.55)
There are currently one hundred twenty trending fundamental ratios for ProKidney Corp that can be evaluated and compared over time across competitors. We recommend to check out ProKidney Corp's recent fundamental drivers against the all of the trends between 2010 and 2026. The value of Market Cap is estimated to slide to about 410.3 M. The Enterprise Value is projected to slide to about 305.5 M

ProKidney Corp Total Revenue

91,770

Check ProKidney Corp financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among ProKidney Corp's main balance sheet or income statement drivers, such as Depreciation And Amortization of 6.6 M, Interest Expense of 9.8 K or Selling General Administrative of 34.9 M, as well as many indicators such as Price To Sales Ratio of 1.7 K, Dividend Yield of 0.0 or Days Sales Outstanding of 9.4 K. ProKidney financial statements analysis is a perfect complement when working with ProKidney Corp Valuation or Volatility modules.
  
Build AI portfolio with ProKidney Stock
Check out the analysis of ProKidney Corp Correlation against competitors.
For more information on how to buy ProKidney Stock please use our How to buy in ProKidney Stock guide.

ProKidney Corp Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets267 M507.2 M141.6 M
Slightly volatile
Short and Long Term Debt Total2.6 M3.7 M1.8 M
Slightly volatile
Other Current Liabilities37.6 M35.8 M9.7 M
Slightly volatile
Total Current Liabilities43.7 M41.6 M11.9 M
Slightly volatile
Net Tangible Assets609.7 M580.7 M170.1 M
Slightly volatile
Property Plant And Equipment Net54.6 M52 M15.7 M
Slightly volatile
Accounts Payable2.9 M4.2 M1.6 M
Slightly volatile
Cash126.6 M114 M62.8 M
Slightly volatile
Non Current Assets Total54.6 M52 M16.3 M
Slightly volatile
Cash And Short Term Investments229.5 M412 M119.4 M
Slightly volatile
Common Stock Shares Outstanding69.1 M88.1 M81.3 M
Very volatile
Liabilities And Stockholders Equity267 M507.2 M141.6 M
Slightly volatile
Non Current Liabilities Total2.4 M3.7 M1.7 M
Slightly volatile
Other Current Assets42.4 M40.4 M8.9 M
Slightly volatile
Total Liabilities47.6 M45.4 M13.7 M
Slightly volatile
Total Current Assets242.6 M455.3 M127 M
Slightly volatile
Short Term Debt486.8 K879.8 K290.6 K
Slightly volatile
Intangible Assets299.7 K191.7 K595.8 K
Slightly volatile
Common Stock24.8 K26.1 K74.1 M
Slightly volatile
Property Plant Equipment10.2 M12.3 M6.5 M
Slightly volatile
Good Will427.6 K384.8 K563.4 K
Slightly volatile
Capital Lease Obligations2.8 M3.7 M2.1 M
Slightly volatile
Property Plant And Equipment Gross32.4 M64.7 M21.2 M
Slightly volatile
Capital Stock24.8 K26.1 K86.3 M
Slightly volatile
Net Working Capital267.9 M413.6 M111.8 M
Slightly volatile
Warrants1.3 B1.4 B1.6 B
Slightly volatile
Common Stock Total Equity19.2 K21.6 K23.6 K
Slightly volatile
Capital Surpluse6 M6.7 M7.3 M
Slightly volatile
Net Receivables2.1 M2.8 M1.6 M
Slightly volatile

ProKidney Corp Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization6.6 M6.2 M2.2 M
Slightly volatile
Selling General Administrative34.9 M64.5 M19.3 M
Slightly volatile
Other Operating Expenses119.1 M211.3 M99.7 M
Slightly volatile
Research Development84.1 M146.8 M80.4 M
Slightly volatile
Total Operating Expenses119.1 M211.3 M99.7 M
Slightly volatile
Total Other Income Expense Net23.8 M22.7 M5.6 M
Slightly volatile
Net Interest Income23.8 M22.7 M5.5 M
Slightly volatile
Interest Income23.9 M22.7 M5.5 M
Slightly volatile
Selling And Marketing Expenses756.8 K1.2 M569.4 K
Slightly volatile
Reconciled Depreciation3.3 M6.2 M2 M
Slightly volatile
Cost Of Revenue3 M3.6 M2.3 M
Slightly volatile
Non Operating Income Net Other4.8 M5.4 M5.9 M
Slightly volatile

ProKidney Corp Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation25 M33.8 M11.5 M
Slightly volatile
Depreciation6.6 M6.2 M1.7 M
Slightly volatile
Capital Expenditures35.6 M33.9 M8.6 M
Slightly volatile
End Period Cash Flow123.8 M114 M53.7 M
Slightly volatile
Change To Netincome89.9 M85.6 M23.8 M
Slightly volatile
Change To Liabilities843.4 K887.8 K1.4 M
Very volatile
Begin Period Cash Flow130.1 M69.7 M55.5 M
Slightly volatile
Cash And Cash Equivalents Changes375.8 M422.7 M461.4 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio1.7 K2 K2.1 K
Slightly volatile
Days Sales Outstanding9.4 K10.6 K11.5 K
Slightly volatile
Book Value Per Share2.633.691.6404
Slightly volatile
Stock Based Compensation To Revenue309348380
Slightly volatile
Capex To Depreciation3.34.892.7314
Slightly volatile
EV To Sales2.9 K3.3 K3.6 K
Slightly volatile
Sales General And Administrative To Revenue590664725
Slightly volatile
Research And Ddevelopement To Revenue1.3 K1.5 K1.7 K
Slightly volatile
Capex To Revenue311349381
Slightly volatile
Cash Per Share2.453.291.5209
Slightly volatile
Income Quality0.880.890.8959
Slightly volatile
Intangibles To Total Assets4.0E-45.0E-40.0287
Slightly volatile
Net Debt To EBITDA0.760.540.8197
Very volatile
Current Ratio10.829.849.0009
Slightly volatile
Tangible Book Value Per Share2.633.691.6328
Slightly volatile
Receivables Turnover0.02490.0280.0305
Slightly volatile
Capex Per Share0.140.270.0875
Slightly volatile
Revenue Per Share6.0E-47.0E-48.0E-4
Slightly volatile
Interest Debt Per Share0.02820.02980.0234
Slightly volatile
Debt To Assets0.0080.00840.0431
Slightly volatile
Operating Cycle9.4 K10.6 K11.5 K
Slightly volatile
Ebt Per Ebit1.051.030.9866
Pretty Stable
Quick Ratio10.829.849.0009
Slightly volatile
Net Income Per E B T0.80.430.8617
Slightly volatile
Cash Ratio2.342.466.6854
Very volatile
Cash Conversion Cycle9.4 K10.6 K11.5 K
Slightly volatile
Days Of Sales Outstanding9.4 K10.6 K11.5 K
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio0.931.111.0686
Slightly volatile
Fixed Asset Turnover0.00130.00150.0017
Slightly volatile
Debt Ratio0.0080.00840.0431
Slightly volatile
Price Sales Ratio1.7 K2 K2.1 K
Slightly volatile
Asset Turnover1.0E-42.0E-42.0E-4
Slightly volatile

ProKidney Corp Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap410.3 M431.9 M1.5 B
Slightly volatile
Enterprise Value305.5 M321.6 M1.4 B
Slightly volatile

ProKidney Fundamental Market Drivers

ProKidney Upcoming Events

26th of March 2024
Upcoming Quarterly Report
View
9th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
26th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About ProKidney Corp Financial Statements

ProKidney Corp investors utilize fundamental indicators, such as revenue or net income, to predict how ProKidney Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue-3.3 M-3.4 M
Total Revenue87.4 K91.8 K
Cost Of Revenue3.6 M3 M
Stock Based Compensation To Revenue 347.83  309.18 
Sales General And Administrative To Revenue 664.15  590.36 
Research And Ddevelopement To Revenue1.5 K1.3 K
Capex To Revenue 349.45  310.62 
Ebit Per Revenue-2.2 K-2.3 K

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Prophet
When determining whether ProKidney Corp is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if ProKidney Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Prokidney Corp Stock. Highlighted below are key reports to facilitate an investment decision about Prokidney Corp Stock:
How To Invest In ProKidney
Details
Is ProKidney Stock a good investment?
Details
What is ProKidney Corp's Net Worth?
Details
Largest Biotechnology Companies
View
Largest Pharmaceuticals, Biotechnology & Life Sciences Companies
View
Check out the analysis of ProKidney Corp Correlation against competitors.
For more information on how to buy ProKidney Stock please use our How to buy in ProKidney Stock guide.
You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ProKidney Corp. Anticipated expansion of ProKidney directly elevates investor willingness to pay premium valuations. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive ProKidney Corp assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share
(0.55)
Revenue Per Share
0.006
Return On Assets
(0.26)
Return On Equity
(0.42)
Investors evaluate ProKidney Corp using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating ProKidney Corp's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. External factors like market trends, sector rotation, and investor psychology can cause ProKidney Corp's market price to deviate significantly from intrinsic value.
Altman
Z Score
Details
Piotroski
F Score
Details
Beneish
M Score
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Earnings
Projections
Details
It's important to distinguish between ProKidney Corp's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding ProKidney Corp should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, ProKidney Corp's market price signifies the transaction level at which participants voluntarily complete trades.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY